ExactScience vs SceneXplain

Side-by-side comparison · Updated May 2026

 ExactScienceExactScienceSceneXplainSceneXplain
DescriptionExact Sciences Corp. is a leading molecular diagnostics company focused on transforming cancer care through prevention, early detection, and treatment guidance. Their cutting-edge product portfolio includes non-invasive screening tests like Cologuard® for colorectal cancer, Oncotype DX® for predicting cancer recurrence, and OncoExTra® for genomic profiling. The company also offers Riskguard™ for hereditary cancer risk assessment and is pioneering multi-cancer early detection tests. Committed to innovation and scientific validation, Exact Sciences plays a pivotal role in cancer diagnostics, earning endorsements from clinical guidelines and continuous certification as a Great Place to Work®.The Scenex Ethics Policy is designed to guide employees in upholding the company's values and maintaining its reputation through ethical conduct. Key areas covered include confidentiality, conflicts of interest, professional behavior, compliance and reporting, and disciplinary actions. Adhering to these guidelines ensures every employee acts responsibly and in the best interest of the company.
CategoryHealthcareOther
RatingNo reviewsNo reviews
PricingFreePricing unavailable
Starting PriceFreeN/A
Plans
  • 7-Day Free TrialFree
  • Keyword Credit SystemUsage-based
  • Potential Feature TiersPricing unavailable
  • Enterprise Custom PricingContact for pricing
Use Cases
  • Healthcare providers
  • Oncologists
  • Patients with liver conditions
  • Genetic counselors
  • New Employees
  • Managers
  • Compliance Officers
  • HR Departments
Tags
molecular diagnosticscancer carepreventionearly detectiontreatment guidance
EthicsPolicyGuidelines
Features
Comprehensive suite of cancer tests across the care continuum, including early detection and screening.
Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening.
Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment.
Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection.
Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits.
OncoExTra® test for aiding late-stage cancer therapy selection.
Supports patient and provider through logins for test ordering and results tracking.
Backed by extensive scientific research, publications, and clinical studies.
Engages in community outreach and health equity initiatives.
Covers confidentiality rules
Guidelines on conflicts of interest
Standards for professional behavior
Requirements for compliance and reporting
Disciplinary actions detailed
Applicable to all employees
Focuses on upholding company values
Reporting mechanism for policy breaches
Protection of trade secrets
Alignment with external laws and regulations
 View ExactScienceView SceneXplain

Modify This Comparison